{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:56:03Z","timestamp":1794959763012,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ygyno.2014.11.076","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T01:18:55Z","timestamp":1420679935000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":514,"title":["Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test"],"prefix":"10.1016","volume":"136","clinical-trial-number":[{"clinical-trial-number":"nct00709891","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Thomas C.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.11.076_bb0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"155","author":"Whitlock","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0020","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/01.AOG.0000438960.31355.9e","article-title":"Practice Bulletin No. 140: Management of abnormal cervical cancer screening test results and cervical cancer precursors","volume":"122","author":"American College of Gynecologists and Obstetricians","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition\u2014summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0035","series-title":"National Cervical Screening Program","year":"2014"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0040","series-title":"Cervical cancer screening in the Netherlands","year":"2014"},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2014.11.076_bb0045","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0060","doi-asserted-by":"crossref","first-page":"46e1-11","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0070","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0075","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0080","series-title":"Blaustein's pathology of the female genital tract","first-page":"193","article-title":"Chapter 5: precancerous lesions of the cervix","author":"Wright","year":"2011"},{"issue":"184","key":"10.1016\/j.ygyno.2014.11.076_bb0085","first-page":"e1","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0090","series-title":"Bootstrapping Methods: A Practitioner's Guide","author":"Chernick","year":"1999"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0110","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0125","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0135","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0140","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG Practice Bulletin Number 131: Screening for cervical cancer","volume":"120","author":"Committee on Practice","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0145","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.11.076_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T15:40:50Z","timestamp":1598629250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814015492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0090825814015492"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.076","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}